
Farewell from the Chair
The 30th of June 2026 marked the end of another financial year for Myelopathy.org and this year it is also the day that, after seven years, I am stepping down as Chair and Trustee.
A lot has happened since I first met the whole Myelopathy.org team at the launch party at the House of Lords in May 2019.
As I learned, there was a wonderful Support Group, a rudimentary website, the RECEDE clinical trial and, in the background, the collaboration with AO Spine for RECODE-DCM.
I learned of an embryonic organisation with very little money but, most importantly, there was a group of passionate people with big ideas and a vision to improve education, care, support and research into DCM. Meeting the founders Mark Kotter, Ben Davies and Iwan Sadler, and witnessing this passion and vision, convinced me to get involved.
We have made a huge amount of progress in the last seven years and I would like to highlight some of what we have achieved together:
- We now have an incredible website which is acknowledged as one of the world’s leading sources of information about DCM.
- Our collaboration with AO Spine has had a real impact on the research environment. Together, we established the Top 10 Research Priorities for DCM and established incubators to take forward research into three of these priorities.
- In July 2021 we employed our first member of staff. Zahabiya has been with Myelopathy.org since then and has brought structure and process to the organisation, experience from the charity sector, and an understanding of how to raise much-needed funds. Zahabiya deals with the often hidden day-to-day running of the charity, but also has been instrumental in initiating, planning and implementing our programmes including the pilot helpline, which launched in 2025.
- Finally and most importantly, there is the Support Group, which was founded and is still run by the incredible Iwan Sadler. This essential group is where it all started and is the bedrock of all that we do. This is often where people newly diagnosed with DCM come to find out information, and the incredible people from our community who run this group offer a heartfelt welcome and support. Without them and all our DCM community, we are nothing.
Everything we do at Myelopathy.org is about improving the lives of people with DCM through raising awareness. providing support and furthering research. It has been a privilege to be part of this journey for the last seven years and to work alongside all of you.
Helen Wood
Chair, Board of Trustees

